Global Gut Microbiome Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Gut Microbiome market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Gut Microbiome market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The gut microbiome refers to the complex and diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, residing in the gastrointestinal tract of humans and animals. Comprising trillions of microorganisms, the gut microbiome plays a crucial role in various physiological functions, such as digestion, nutrient absorption, and immune system modulation. The composition of the gut microbiome can be influenced by factors like diet, lifestyle, and antibiotic use. Recent research has highlighted its significance in maintaining overall health, impacting not only digestive processes but also playing a role in metabolism, mental health, and immunity. An imbalance in the gut microbiome, known as dysbiosis, has been associated with various health conditions, emphasizing the importance of understanding and maintaining a healthy microbial balance for overall well-being.
The major global suppliers of Gut Microbiome include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics, Assembly Biosciences, AnimalBiome, Enterome BioScience, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gut Microbiome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Gut Microbiome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gut Microbiome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gut Microbiome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Gut Microbiome Include:
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
Assembly Biosciences
AnimalBiome
Enterome BioScience
Gut Microbiome Product Segment Include:
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Gut Microbiome Product Application Include:
Human
Animal
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Gut Microbiome Industry PESTEL Analysis
Chapter 3: Global Gut Microbiome Industry Porter's Five Forces Analysis
Chapter 4: Global Gut Microbiome Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Gut Microbiome Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Gut Microbiome Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Gut Microbiome Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Gut Microbiome market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China Gut Microbiome market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The gut microbiome refers to the complex and diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, residing in the gastrointestinal tract of humans and animals. Comprising trillions of microorganisms, the gut microbiome plays a crucial role in various physiological functions, such as digestion, nutrient absorption, and immune system modulation. The composition of the gut microbiome can be influenced by factors like diet, lifestyle, and antibiotic use. Recent research has highlighted its significance in maintaining overall health, impacting not only digestive processes but also playing a role in metabolism, mental health, and immunity. An imbalance in the gut microbiome, known as dysbiosis, has been associated with various health conditions, emphasizing the importance of understanding and maintaining a healthy microbial balance for overall well-being.
The major global suppliers of Gut Microbiome include Viome, Carbiotix, Ixcela, Inc, Novome Biotechnologies, Kintai Therapeutics, ProDigest, Caelus Health, LNC Therapeutics, Assembly Biosciences, AnimalBiome, Enterome BioScience, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gut Microbiome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Gut Microbiome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gut Microbiome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gut Microbiome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Gut Microbiome Include:
Viome
Carbiotix
Ixcela, Inc
Novome Biotechnologies
Kintai Therapeutics
ProDigest
Caelus Health
LNC Therapeutics
Assembly Biosciences
AnimalBiome
Enterome BioScience
Gut Microbiome Product Segment Include:
Obesity
Inflammatory Bowel Disease (IBD)
Diabetes
Others
Gut Microbiome Product Application Include:
Human
Animal
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Gut Microbiome Industry PESTEL Analysis
Chapter 3: Global Gut Microbiome Industry Porter's Five Forces Analysis
Chapter 4: Global Gut Microbiome Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Gut Microbiome Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Gut Microbiome Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Gut Microbiome Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Gut Microbiome Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Gut Microbiome Product by Type
- 1.2.1 Obesity
- 1.2.2 Inflammatory Bowel Disease (IBD)
- 1.2.3 Diabetes
- 1.2.4 Others
- 1.3 Gut Microbiome Product by Application
- 1.3.1 Human
- 1.3.2 Animal
- 1.4 Global Gut Microbiome Market Size Analysis (2020-2032)
- 1.5 Gut Microbiome Market Development Status and Trends
- 1.5.1 Gut Microbiome Industry Development Status Analysis
- 1.5.2 Gut Microbiome Industry Development Trends Analysis
- 2 Gut Microbiome Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Gut Microbiome Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Gut Microbiome Market Analysis by Country
- 4.1 Global Gut Microbiome Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Gut Microbiome Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Gut Microbiome Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.5 China Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.6 France Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.14 India Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Gut Microbiome Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Gut Microbiome Market Revenue by Key Suppliers (2021-2025)
- 5.2 Gut Microbiome Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Gut Microbiome Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Gut Microbiome Market Analysis by Type
- 6.1 Global Gut Microbiome Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Gut Microbiome Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Viome
- 7.1.1 Viome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Viome Gut Microbiome Product Portfolio
- 7.1.3 Viome Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Carbiotix
- 7.2.1 Carbiotix Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Carbiotix Gut Microbiome Product Portfolio
- 7.2.3 Carbiotix Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Ixcela, Inc
- 7.3.1 Ixcela, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Ixcela, Inc Gut Microbiome Product Portfolio
- 7.3.3 Ixcela, Inc Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Novome Biotechnologies
- 7.4.1 Novome Biotechnologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Novome Biotechnologies Gut Microbiome Product Portfolio
- 7.4.3 Novome Biotechnologies Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Kintai Therapeutics
- 7.5.1 Kintai Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Kintai Therapeutics Gut Microbiome Product Portfolio
- 7.5.3 Kintai Therapeutics Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 ProDigest
- 7.6.1 ProDigest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 ProDigest Gut Microbiome Product Portfolio
- 7.6.3 ProDigest Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Caelus Health
- 7.7.1 Caelus Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Caelus Health Gut Microbiome Product Portfolio
- 7.7.3 Caelus Health Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 LNC Therapeutics
- 7.8.1 LNC Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 LNC Therapeutics Gut Microbiome Product Portfolio
- 7.8.3 LNC Therapeutics Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Assembly Biosciences
- 7.9.1 Assembly Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Assembly Biosciences Gut Microbiome Product Portfolio
- 7.9.3 Assembly Biosciences Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 AnimalBiome
- 7.10.1 AnimalBiome Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 AnimalBiome Gut Microbiome Product Portfolio
- 7.10.3 AnimalBiome Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Enterome BioScience
- 7.11.1 Enterome BioScience Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Enterome BioScience Gut Microbiome Product Portfolio
- 7.11.3 Enterome BioScience Gut Microbiome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Gut Microbiome Industry Chain Analysis
- 8.2 Gut Microbiome Product Downstream Application Analysis
- 8.2.1 Global Gut Microbiome Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Gut Microbiome Revenue and Forecast by Application (2020-2032)
- 8.3 Gut Microbiome Typical Downstream Customers
- 8.4 Gut Microbiome Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
